Literature DB >> 32029604

Will novel virus go pandemic or be contained?

Kai Kupferschmidt1, Jon Cohen1.   

Abstract

Mesh:

Year:  2020        PMID: 32029604     DOI: 10.1126/science.367.6478.610

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  21 in total

1.  In silico drug repurposing for coronavirus (COVID-19): screening known HCV drugs against the SARS-CoV-2 spike protein bound to angiotensin-converting enzyme 2 (ACE2) (6M0J).

Authors:  Konstantinos G Kalamatianos
Journal:  Mol Divers       Date:  2022-06-23       Impact factor: 3.364

Review 2.  Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting viruses.

Authors:  Rahul Kumar; Sahil Mishra; Sushil K Maurya
Journal:  RSC Med Chem       Date:  2020-12-23

3.  Factors Influencing Mental Health of Medical Workers During the COVID-19 Outbreak.

Authors:  Yan Zhang; Simiao Xie; Pu Wang; Guixiang Wang; Li Zhang; Xiaochen Cao; Wenzhi Wu; Yueran Bian; Fei Huang; Na Luo; Mingyan Luo; Qiang Xiao
Journal:  Front Public Health       Date:  2020-09-22

Review 4.  Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.

Authors:  Muhammad Bilal; Hafiz M N Iqbal
Journal:  Hum Vaccin Immunother       Date:  2020-08-26       Impact factor: 3.452

5.  COVID-19 Biomarkers in research: Extension of the OncoMX cancer biomarker data model to capture biomarker data from other diseases.

Authors:  N Gogate; D Lyman; K A Crandall; R Kahsay; D A Natale; S Sen; R Mazumder
Journal:  bioRxiv       Date:  2020-09-10

6.  Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases.

Authors:  Cynthia Liu; Qiongqiong Zhou; Yingzhu Li; Linda V Garner; Steve P Watkins; Linda J Carter; Jeffrey Smoot; Anne C Gregg; Angela D Daniels; Susan Jervey; Dana Albaiu
Journal:  ACS Cent Sci       Date:  2020-03-12       Impact factor: 14.553

7.  A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials.

Authors:  Vaishali M Patil; Shipra Singhal; Neeraj Masand
Journal:  Life Sci       Date:  2020-05-11       Impact factor: 5.037

8.  An in-silico evaluation of COVID-19 main protease with clinically approved drugs.

Authors:  Wafa Tachoua; Mohamed Kabrine; Mamona Mushtaq; Zaheer Ul-Haq
Journal:  J Mol Graph Model       Date:  2020-09-21       Impact factor: 2.518

Review 9.  Potential small-molecule drugs as available weapons to fight novel coronavirus (2019-nCoV): A review.

Authors:  Vahid Rahimkhoei; Nassrollah Jabbari; Aynaz Nourani; Sina Sharifi; Ali Akbari
Journal:  Cell Biochem Funct       Date:  2020-08-17       Impact factor: 3.963

Review 10.  Challenges and prospects of COVID-19 vaccine development based on the progress made in SARS and MERS vaccine development.

Authors:  Jubeda Begum; Nasir Akbar Mir; Kapil Dev; Bidyarani Buyamayum; Mohd Yaqoob Wani; Meesam Raza
Journal:  Transbound Emerg Dis       Date:  2020-09-23       Impact factor: 4.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.